Filing Flows

Filing Flows › Relay Therapeutics (RLAY) › Next earnings date

Relay Therapeutics (RLAY) earnings: beat the estimate

Relay Therapeutics (RLAY) reported on Nov 4, 2026 and beat the EPS estimate: −$0.37 against −$0.40 (+7.8%). It beat the EPS estimate in 40% of the quarters on record.

Last result+7.8% vs estimate
Beat rate40%

The last report

Relay Therapeutics reported revenue of $350K for the second quarter 2026 (-48% Y/Y), net loss $83.7M. How it makes money → · Every quarter →

Relay Therapeutics: EPS against the estimate, last 5 reportsRelay Therapeutics: EPS against the estimate, last 5 reportsEstimateReported−$0.42−$0.43Nov 25−$0.40−$0.31Feb 26−$0.36−$0.41May 26−$0.39−$0.41Aug 26−$0.40−$0.37Nov 26
Latest (Nov 26): Estimate −$0.40, Reported −$0.37.

Relay Therapeutics' latest quarter

Relay Therapeutics, Q2 2026: revenue $350K (-48% year over year), net loss $83.7M, operating cash flow −$54.1M. The chart follows the revenue to costs, profit and cash.

Questions

Did Relay Therapeutics beat earnings?

Relay Therapeutics (RLAY) reported on Nov 4, 2026 and beat the EPS estimate: −$0.37 against −$0.40 (+7.8%).

When does RLAY report earnings?

The next date is not set yet.

Does Relay Therapeutics usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.